Investıgatıon Of The Effectıveness Of The Mollıı Suıt In Chıldren Wıth Ambulatory Cerebral Palsy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-18
SponsorKastamonu University

About this trial

Cerebral Palsy (CP) is the most common developmental disorder in childhood. Individuals' independence in daily living activities and participation in education, games, social and community activities are restricted. Technology applications in the field of rehabilitation are gaining momentum. EXOPULSE Mollii Suit method, one of the newest rehabilitation technology products, is a non-invasive neuromodulation approach with a garment that covers the whole body and electrodes placed inside. Designed to improve motor function by reducing spasticity and pain, the method is based on the principle of reciprocal inhibition, which occurs by stimulating the antagonist of a spastic muscle at low frequencies and intensities. Therefore, the aim of our study is to examine the effectiveness of the Mollii Suit application on gross and fine motor function, spasticity severity, balance, walking, selective motor control, postural control, daily living activities, quality of life, pain and sleep quality in individuals with ambulatory spastic CP.

Eligibility criteria

Qualifiers

Being a voluntary participant in the study,

Having a diagnosis of spastic CP,

Being between 1-3 on the Gross Motor Classification System (GMFCS),

Being between the ages of 4 and 18,

Disqualifiers

Being between 4-5 on Gross Motor Classification System (GMFCS)

Having Botolunim Toxin A application before 3 months

Having a surgical intervention before 6 months

Having a shunt or an invasive medical pump (baclofen, insulin, etc.)

Trial design

Treatments tested in this trial

  • EXOPULSE Mollii Suit

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Kastamonu University

Lead sponsor

Gazi University

Collaborator